A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Clinical trial NCT05269355 · TERMINATED
Trial details
- NCT number
- NCT05269355
- Sponsor
- PTC Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2024-06-17
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.